PRQR
#3492
ProQR Therapeutics N.V. - Ordinary Shares
2.2 9 USD
-0.01%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-1.29%
Variazione Mensile
+31.61%
Variazione di 6 mesi
+48.70%
Variazione Annuale
+2.23%
Chiusura Precedente
2.3 2
Open
2.2 9
Minimo
2.2 9
Massimo
2.2 9
Volume
19
Financials
- Market Capitalization 241.28 M
- Employee 187
- Founded 2012
- CEO Daniel A. de Boer
- Website www.proqr.com
- Headquarter Netherlands
- FIGI UNKNOWN
- Industry Biotecnologia
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3480 |  CGEN Compugen Ltd. - Ordinary Shares | 2.60 USD | -5.80% | +0.78% | +15.04% | +83.10% | 245.84 M USD | ||
| 3487 |  CLLS Cellectis S.A. - American Depositary Shares | 3.40 USD | -3.13% | +5.26% | +20.57% | +32.30% | 243.95 M USD | ||
| 3517 |  RNA Atrium Therapeutics, Inc. - Common Stock | 13.64 USD | -2.43% | +2.79% | +20.39% | -80.61% | 233.32 M USD | ||
| 3519 |  TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 13.59 USD | +0.22% | +5.43% | +44.11% | -9.46% | 233.08 M USD |